Skip to contentSkip to filters

We use cookies for analytics.

Factor XI/XIa Inhibitors for Stroke Prevention: Evolving Evidence and Clinical Relevance

John Eikelboom, Ashkan Shoamanesh and Gisele Sampaio Silva

McMaster University, Canada; McMaster University; Population Health Research Institute (PHRI), Canada; Federal University of São Paulo; Albert Einstein Hospital, Brazil

Recording

1 h 3 min

Abstract

An in-depth review of the emerging evidence on factor XI and factor XIa inhibitors for stroke prevention, their clinical implications and the likely future directions for antithrombotic therapy. John Eikelboom explains the mechanism of action of factor XI/XIa inhibitors and their role in preventing stroke; Ashkan Shoamanesh presents recent clinical-trial findings on their safety and efficacy; and Gisele Sampaio Silva considers how these agents may change current antithrombotic treatment strategies in stroke prevention.

Topics